May 09, 2020

Innovations from enucleation: Where can we go from here? Ocular enucleation is inevitable for some patients; but for others, new therapies might spare the eye. If it must happen, there are ways to ease that road for patients. Read more ADVERTISEMENT   Blockchain technology aims to drive big data to ‘train’ AI Artificial Intelligence is the subject of numerous articles that tout how well machines function better than human ophthalmologists, but why is this happening? Find out

The dropless future: SLT as a first-line treatment for glaucoma Drop tolerance and adherence are glaucoma medication challenges that physicians and their patients have wrestled with for years. But with advances in laser technology improving laser safety and recent research demonstrating SLT efficacy and safety, drops do not have to be the first line of treatment. Learn more

RELATED ARTICLES

Pharmacologic treatment an option for open-angle glaucoma Genetics analysis may predict myopia in children Putting technologies into practice not perfect science Diagnosing LSCD noninvasively: SD-OCT preferred technology Researchers eye cure, diagnostics for adenoviral conjunctivitis Fluorescein angiography key in diagnosing retinal diseases Corneal ectasia: Effects of epi-on and epi-off CXL Caution key when embracing new technologies in clinical practice